High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis-Reference-Cited by-同舟云学术

High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis

Published:2016-08 Issue:12 Volume:49 Page:890-896
ISSN:0009-9120
Container-title:Clinical Biochemistry
language:en
Short-container-title:Clinical Biochemistry

Author:

Giotakis Aris I.,Kontos Christos K.,Manolopoulos Leonidas D.,Sismanis Aristides,Konstadoulakis Manousos M.,Scorilas Andreas

Publisher

Elsevier BV

Subject

Clinical Biochemistry,General Medicine

Reference43 articles.

1. Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1–T2 oral squamous cell carcinoma patients;Jerjes;Head Neck Oncol.,2010

2. Letter to the editors: essentials for an updated epidemiology of laryngeal carcinoma;Marioni;Cancer Treat. Rev.,2012

3. Cancer statistics, 2010;Jemal;CA Cancer J. Clin.,2010

4. Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluation;Lothaire;Head Neck,2006

5. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics;Kerr;Br. J. Cancer,1972

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Different duration of exposure to a pulsed magnetic field can cause changes in mRNA expression of apoptotic genes in oleic acid-treated neuroblastoma cells;International Journal of Radiation Biology;2024-08

2. Functional analysis of a putative HER2-associated expressed enhancer, Her2-Enhancer1, in breast cancer cells;Scientific Reports;2023-11-09

3. Functional analysis of a putative HER2-associated expressed enhancer, Her2- Enhancer1, in breast cancer cells;2023-01-19

4. Xanthotoxin modulates oxidative stress, inflammation, and MAPK signaling in a rotenone-induced Parkinson's disease model;Life Sciences;2022-12

5. A Systematic Review on a comprehensive evaluation of clinical prognostic variables and new biomarkers for head and neck cancer outcome;2022-11-30